RMTI Rockwell Medical, Inc. (DE) Common Stock PHARMACEUTICAL PREPARATIONS Best Pharmaceutical Stocks 2026 →

Rockwell Medical, Inc. (DE) (RMTI) Stock: Buy, Sell, or Hold?

$7.03
-0.35 (-4.74%) ▼
5d: -9.06% 30d: -11.9% 90d: -6.08%
QUANTITATIVE VERDICT
HOLD
MODERATE Confidence (80%)
Quality Score
57/100
Position
OVERSOLD
30-Day Fair Range
$7.07 – $7.90
Position: OVERSOLD
Forward P/E & Valuation
-34.3x CHEAP
vs 17.3x historical avg
Wall Street Target
$20.00
+184.5% upside
Options IV & Volume
HIGH Vol
HIGH volume confirmation
Support / Resistance
$6.75 / $8.39
Trend: Uptrend
💡Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
📊 HOLD: RMTI shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.

Get Alerted When RMTI Hits Your Target Price

Join 10,000+ traders who never miss a move

You're in! Check your email to confirm and set your target price.
100% Free No spam, ever Unsubscribe anytime

Interactive Price Chart (1 Month)

Loading chart...

Loading historical data...

In-depth Analysis How we analyze

Valuation Analysis: RMTI is currently trading at $7.03, which is considered oversold relative to its 30-day fair value range of $7.07 to $7.90. From a valuation perspective, the stock is trading at a discount (Forward PE: -34.3) compared to its historical average (17.3). At these levels, the market is pricing in 0% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.

Technical Outlook: Technically, RMTI is in a uptrend. Immediate support is located at $6.75, while resistance sits at $8.39. Short-term momentum is weak, with the stock down 4.7% recently.

Market Sentiment: The stock scores a mixed 55/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $20.00 (+184.5%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.

Quick Decision Summary

Current Position OVERSOLD
Historical Trading Range $7.07 - $7.90
Company Quality Score 57/100 (HOLD)
Volume Confirmation HIGH
Confidence Score 79.5%

Trading Range & Key Levels

30-Day Trading Range $7.07 - $7.90
Current vs Trading Range OVERSOLD
Support Level $6.75
Resistance Level $8.39
Current Trend Uptrend
Technical data as of Nov 13, 2026

Quantitative Signal Breakdown

  • BULLISH: Price oversold vs 30-day range
  • NEUTRAL: Mixed technical signals (55/100)
  • BULLISH: High volume confirmation
  • BEARISH: Downward momentum (-4.7%)
  • BULLISH: Trading 184.5% below Wall St target ($20.00)
  • BULLISH: Market expects only 0% annual growth - appears undervalued
  • NEUTRAL: Bottoming setup forming (55/100) — watch for confirmation
  • CAUTION: 5-day price weakness (-9.1%) - monitor closely

Fundamental Context

Forward P/E (Next Year Est.) -34.29
Wall Street Target $20.00 (+184.5%)
Revenue Growth (YoY) 10.6%
Profit Margin -7.3%
PE vs Historical -34.3 vs 17.3 CHEAP
Share RMTI Analysis

Share this live RMTI analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.

bloggers & journalists: you are free to use our charts with attribution.

Reddit & Retail Trader Sentiment (RMTI)

Bullish 1 Retail Mentions
StockTwits Volume
1 msgs
24h retail stream
Last Tracked
Nov 13, 2026
Daily AI digest
AI Retail Discussion Summary: Bullish sentiment on StockTwits regarding potential interest in Rockwell Medical's Vantive products. Q3 2026 earnings call summary reports a loss but surpasses revenue estimates.
Key Retail Themes: Company earnings Product interest
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams. View All Trending Reddit & WSB Stocks →
Last updated: November 13, 2026 5:46 PM ET
Data refreshes hourly during market hours. Next update: 6:46 PM
🔥 Top Stocks Breaking Out Now
Ticker Score Recommendation Change %
Technical Signals Check
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL

Unlock Insider Activity

See real-time buying/selling by company executives for RMTI.

Create Free Account

Already have an account? Log In

Top Rated Drug Manufacturers - Specialty & Generic Stocks

Top-rated stocks in Drug Manufacturers - Specialty & Generic by analyst ratings.

Stock Analyst Consensus Analyst Target Tradestie Score
NBIX
Neurocrine Biosciences I…
STRONG BUY
29 analysts
$208 30 SELL
ALKS
Alkermes Plc
STRONG BUY
20 analysts
$58 39 SELL
TEVA
Teva Pharma Industries L…
STRONG BUY
15 analysts
$49 47 HOLD
AMLX
Amylyx Pharmaceuticals I…
STRONG BUY
12 analysts
$43 55 HOLD
AQST
Aquestive Therapeutics I…
STRONG BUY
9 analysts
$9 59 HOLD

Explore More Analysis & Live Quant Tools

Part A: Deep-Dive RMTI Research Pages
RMTI Technical Chart RMTI Price Prediction RMTI Intrinsic Value DCF RMTI Earnings Date RMTI Investment Advisor RMTI Fair Price Analyzer RMTI Competitors
Part B: Tradestie Flagship Market Scanners
Live Trades
From trading groups
Loading trades...
View All Live Trades See Trader Consensus & Signals